Lee, J. L. http://orcid.org/0000-0003-1334-7671
Foschini, L. http://orcid.org/0000-0003-1409-3570
Kumar, S.
Juusola, J.
Liska, J.
Mercer, M.
Tai, C.
Buzzetti, R.
Clement, M.
Cos, X.
Ji, L.
Kanumilli, N.
Kerr, D. http://orcid.org/0000-0003-1335-1857
Montanya, E. http://orcid.org/0000-0003-2518-9076
Müller-Wieland, D.
Ostenson, C. G.
Skolnik, N.
Woo, V.
Burlet, N.
Greenberg, M.
Samson, S. I. http://orcid.org/0000-0001-8365-5093
Funding for this research was provided by:
Sanofi
Article History
Received: 4 January 2021
Accepted: 25 August 2021
First Online: 17 September 2021
Competing interests
: Lee, Jennifer L. Conflicts of interest to declare: Employed by Evidation, Foschini, Luca, Conflicts of interest to declare: Co-founder and employee of Evidation, Kumar, Shefali, Conflicts of interest to declare: Previously employed by Evidation during conduct of the study, Juusola, Jessie, Conflicts of interest to declare: Previously employed by Evidation during conduct of the study, Liska, Jan, Conflicts of interest to declare: Employed by Sanofi, Mercer, Monica, Conflicts of interest to declare: Employed by Sanofi Pasteur Tai, Caroline, Conflicts of interest to declare: Previously employed by Evidation during conduct of the study, Buzzetti, Raffaella, Conflicts of interest to declare: Personal fees from Eli Lilly, personal fees from Sanofi, personal fees from Novo Nordisk, personal fees from AstraZeneca, personal fees from Abbott, personal fees from Merck Sharp and Dohme, outside the submitted work for invited speaker engagement Clement, Maureen, Conflicts of interest to declare: Personal fees from Sanofi, personal fees from Novo Nordisk, personal fees from Abbott, personal fees from Lilly, outside the submitted work Cos, Xavier, Conflicts of interest to declare: fees as consultant from AstraZeneca, Boehringer Ingelheim, Lilly, Novartis, Novo Nordisk and Sanofi Diabetes, Sanofi Pasteur, Esteve and research support from AstraZeneca, Novartis, Sanofi, Boehringer Ingelheim Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, Lilly, Novartis, Novo Nordisk, Sanofi Diabetes, Sanofi Pasteur. Ji, Linong, Conflicts of interest to declare: None Kanumilli, Naresh, Conflicts of interest to declare: Personal fees from Sanofi Pasteur, during the conduct of the study, Kerr, David, Conflicts of interest to declare: Received honoraria for participation in Advisory Boards for Sanofi Pasteur and NovoNordisk. He also is in receipt of share options from Glooko and research funding from Lilly and Abbott Montanya, Eduard, Conflicts of interest to declare: Personal fees from AstraZeneca, personal fees from Merck Sharp & Dohme, personal fees from Novartis, personal fees from NovoNordisk, personal fees from Sanofi, personal fees from Servier, grants from Menarini, outside the submitted work Müller-Wieland, Dirk, Conflicts of interest to declare: Personal fees from Amgen, personal fees from AstraZeneca, personal fees from Böhringer Ingelheim, personal fees from MSD/Merck, personal fees from Novo Nordisk, personal fees from Bayer Vital, personal fees from Sanofi, outside the submitted work Ostenson, Claes Goran, Conflicts of interest to declare: None Skolnik, Neil, Conflicts of interest to declare: Advisory Boards -AstraZeneca, Teva, Lilly, Boehringer, Ingelheim, Sanofi, Sanofi Pasteur, Janssen Pharmaceuticals, Intarcia, Mylan, GSK, Merck, Bayer. Speaker - AstraZeneca; Boehringer Ingelheim; Lilly, GSK. Research, Support - Sanofi, AstraZeneca, Boehringer Ingelheim, GSK, Bayer, Woo, Vincent, Conflicts of interest to declare: Serves on advisory board for Sanofi, Burlet, Nansa, Conflicts of interest to declare: Was an employee at Sanofi Aventis Group at the time of study execution and is now employed at Kyowa Kirin International Greenberg, Michael, Conflicts of interest to declare: Employed by Sanofi Pasteur Samson, Sandrine. Conflicts of interest to declare: Employed by Sanofi Pasteur.